newsfilter
← Latest News
GlobeNewswire·

Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website

SAN DIEGO, March 31, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ:BLTE), a clinical-stage development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant